HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Aethlon Medical, Inc. (AEMD)
5.22  -0.14  (-2.61%) 06-21 03:26
Open: 5.21 High: 5.3481
Pre.close: 5.36 Low: 5.05
Volume: 849,222 Ave vol: 5,274,607
52w High: 12.49 52w Low: 1.22
MA(50): 2.913 MA(200): 2.397
EPS: -0.706 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.aethlonmedical.com
Market Cap (M): 63
Shares Out (M): 12
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The firm operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The firm's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 9.70 Target 2: 14.59
Resist 1: 8.30 Resist 2: 12.49
Support 1: 1.53 Support 2: 1.27
Company key metrics
Revenue per Share: 0.1904
Net Income per Share: -1.8665
Cash per Share: 2.8127
Book Value per Share: 2.7168
Price to Sales: 7.3529
Price to Book Value: 0.5153
Earnings Yield: -1.3332
Dividend Yield: 0
Debt to Equity: 0
Debt to Assets: 0.1069
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.